Viz Cardiac Amyloidosis
AI-Powered Detection and Care Pathway for Cardiac Amyloidosis
Identify suspected ATTR-CM earlier with AI-powered echocardiogram analysis and accelerate diagnosis through coordinated heart failure workflows.
The Heart Failure Gap
An Underdiagnosed Cause of Heart Failure
Cardiac amyloidosis is a progressive, restrictive cardiomyopathy that often presents as heart failure with preserved ejection fraction (HFpEF). Despite growing awareness, up to 80% of cases remain undiagnosed, with delays that can span years.
Outcomes depend on early identification. Available therapies can slow progression but only if patients are diagnosed in time. Every delay is a missed opportunity to intervene.
Viz Cardiac Amyloidosis is designed to help close this gap—supporting earlier identification and coordinated care into everyday clinical workflows, by:
- Flagging suspected ATTR-CM from newly ingested echocardiograms
- Surfacing structured echo measurements powered by FDA-cleared algorithms
- Integrating with EHR to provide heart failure–specific, tailored patient summaries
AI Detection Support from Echocardiography
Viz integrates FDA-cleared echocardiogram AI measurement and cardiac amyloidosis detection algorithms to analyze newly ingested studies and flag suspected cases in real time.
Care teams receive a clear, actionable signal within their existing workflow—
Supporting clinical review and reducing reliance on manual red flag recognition.
Integrated Patient Context
EHR integration provides heart failure–specific patient summaries, including medications, labs, and relevant diagnoses—all within the Viz platform.
This may support more efficient clinical decision-making and more efficient diagnostic workups.
Care Pathway Coordination
Designed for cardiac amyloidosis and advanced heart failure programs, Viz helps streamline the path from detection to diagnosis and treatment.
Designed for Advanced Heart Failure and Amyloidosis Programs
Viz Cardiac Amyloidosis is purpose-built for specialized cardiac amyloidosis and advanced heart failure clinics.
As part of the Viz Cardio Suite, it extends a unified platform for cardiovascular care—bringing AI-powered detection and coordinated workflows into routine practice.
This approach expands cardiology footprint while embedding deeply within daily clinical workflow.
Changing the Trajectory of Diagnosis
-
"Viz.ai's performance in this year's report underscores its leadership in AI-driven acute care," said Black Book President Doug Brown. "Its solutions deliver not only speed and clinical precision but also consistent satisfaction across specialties and hospital sizes."
Schedule a meeting to get access
Explore the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.